IngentaConnect Search Results

Haemostatic effect and tissue reactions of methods and agents used for haemorrhage control in apical surgery

Authors: Jensen, S. S.; Yazdi, P. M.; Hjørting-Hansen, E.; Bosshardt, D. D.; von Arx, T.

Source: International Endodontic Journal, Volume 43, Number 1, January 2010 , pp. 57-63(7)

Successful major and minor surgery using factor VIII inhibitor bypassing activity in patients with haemophilia A and inhibitors

Authors: LAUROUA, P.; FERRER, A.-M.; GUÉRIN, V.

Source: Haemophilia, Volume 15, Number 6, November 2009 , pp. 1300-1307(8)

Publisher: Blackwell Publishing

Uncontrolled Bleeding in Surgical Patients: The Role of Recombinant Activated Factor VIIa

Authors: Phillips, L. E.; Zatta, A. J.; Schembri, N. L.; Noone, A. K.; Isbister, J.

Source: Current Drug Targets, Volume 10, Number 8, August 2009 , pp. 744-770(27)

Publisher: Bentham Science Publishers

Endocannabinoid Blockade and the Cardiovascular System

Authors: Keown, Oliver P.; Megson, Ian L.; Leslie, Stephen J.

Source: Current Drug Therapy, Volume 4, Number 2, May 2009 , pp. 111-116(6)

Publisher: Bentham Science Publishers

Intraoperative haemostasis with new fibrin surgical sealant (Quixil®) in gynaecological oncology

Authors: Papacharalabous, E. N.; Giannopoulos, T.; Tailor, A.; Butler-Manuel, S. A.

Source: Journal of Obstetrics & Gynaecology, Volume 29, Number 3, April 2009 , pp. 233-236(4)

Publisher: Informa Healthcare

The role of recombinant activated Factor VII in major obstetric haemorrhage: The Farnborough experience

Authors: Wissa, I.; Ebeid, E.; El-Shawarby, S.; Chandakas, S.; Kamal, T.; Hill, N.

Source: Journal of Obstetrics & Gynaecology, Volume 29, Number 1, January 2009 , pp. 21-24(4)

Publisher: Informa Healthcare

Recombinant activated factor VII in the treatment of non-haemophilia patients: physician under-reporting of thromboembolic adverse events

Authors: Hsia; Zurawska; Tong; Eckert; McAlister; Chin-Yee

Source: Transfusion Medicine, Volume 19, Number 1, February 2009 , pp. 43-49(7)

Publisher: Blackwell Publishing

Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors

Author: BERNTORP, E.

Source: Haemophilia, Volume 15, Number 1, January 2009 , pp. 3-10(8)

Publisher: Blackwell Publishing

Understanding the therapeutic action of recombinant factor VIIa in platelet disorders

Authors: Hers, Ingeborg; Mumford, Andrew

Source: Platelets, Volume 19, Number 8, December 2008 , pp. 571-581(11)

Publisher: Informa Healthcare

Differential clot stabilising effects of rFVIIa and rFXIII-A₂ in whole blood from thrombocytopenic patients and healthy volunteers

Authors: Johansson, Pär I.; Jacobsen, Niels; Viuff, Dorthe; Olsen, Eva H. N.; Rojkjaer, Rasmus; Andersen, Søren; Petersen, Lars C.; Kjalke, Marianne

Source: British Journal of Haematology, Volume 143, Number 4, November 2008 , pp. 559-569(11)

Publisher: Blackwell Publishing

Does topical haemostatic agent have an adverse effect on the function of the prostatic neurovascular bundle?

Authors: Zeltser, Ilia; Dugi, Daniel; Gupta, Amit; Park, Sangtae; Kabbani, Wareef; Cadeddu, Jeffrey

Source: BJU International, Volume 102, Number 8, October 2008 , pp. 1005-1007(3)

Publisher: Blackwell Publishing

Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency

Authors: O'CONNELL, N. M.; RIDDELL, A. F.; PASCOE, G.; PERRY, D. J.; LEE, C. A.

Source: Haemophilia, Volume 14, Number 4, July 2008 , pp. 775-781(7)

Publisher: Blackwell Publishing

The effect of FloSeal on post-tonsillectomy pain: a randomised controlled pilot study

Authors: Blackmore, K.J.; O'Hara, J.; Flood, L.M.; Martin, F.W.

Source: Clinical Otolaryngology, Volume 33, Number 3, June 2008 , pp. 281-284(4)

Publisher: Blackwell Publishing

Cofactor-induced and mutational activity enhancement of coagulation factor VIIa

Authors: Olsen, O.; Persson, E.

Source: Cellular and Molecular Life Sciences CMLS, Volume 65, Number 6, March 2008 , pp. 953-963(11)

Publisher: Springer

A Benefit-Risk Review of Systemic Haemostatic Agents: Part 2: In Excessive or Heavy Menstrual Bleeding

Authors: Fraser, Ian S.; Porte, Robert J.; Kouides, Peter A.; Lukes, Andrea S.

Source: Drug Safety, Volume 31, Number 4, 2008 , pp. 275-282(8)

Publisher: Adis International

Efficacy of a haemostatic matrix for the management of bleeding in patients undergoing liver resection: results from 237 cases

Authors: Izzo, Francesco; Di Giacomo, Raimondo; Falco, Paolo; Piccirillo, Mauro; Iodice, Rossana; Orlando, Antonio Pio; Aprea, Pasquale; Cremona, Francesco; Di Marzo, Massimiliano; Idà, Domenico Nicola; Mastro, Angelo A.; Curley, Steven A.

Source: Current Medical Research and Opinion, Volume 24, Number 4, April 2008 , pp. 1011-1015(5)

Publisher: Informa Healthcare

A Benefit-Risk Review of Systemic Haemostatic Agents: Part 1: In Major Surgery

Authors: Fraser, Ian S.; Porte, Robert J.; Kouides, Peter A.; Lukes, Andrea S.

Source: Drug Safety, Volume 31, Number 3, 2008 , pp. 217-230(14)

Publisher: Adis International

Management of menorrhagia in women with inherited bleeding disorders: general principles and use of desmopressin

Author: RODEGHIERO, F.

Source: Haemophilia, Volume 14, Supplement 1, January 2008 , pp. 21-30(10)

Publisher: Blackwell Publishing

Factor VIII inhibitor bypassing activity (FEIBA) - addressing safety issues

Author: ALEDORT, L. M.